MedTrace Logo

IV Tranexamic Acid Prior to Hysterectomy

NCT02911831 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2022-08-09

No results posted yet for this study

Summary

The objective of this study is to determine the effect of 1g of IV tranexamic acid given within 1 hour pre-operatively on intraoperative blood loss at time of hysterectomy.

Conditions

  • Hysterectomy
  • Blood Loss, Surgical

Interventions

DRUG

Tranexamic Acid

DRUG

Sodium Chloride

Sponsors & Collaborators

Principal Investigators

  • Magdy Milad, MD · Northwestern University, Northwestern Memorial Hopsital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02911831 on ClinicalTrials.gov